HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter Bohlen Selected Research

E4G10 antibody

3/2005Inhibition of the vascular endothelial cell (VE)-specific adhesion molecule VE-cadherin blocks gonadotropin-dependent folliculogenesis and corpus luteum formation and angiogenesis.
5/2002Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter Bohlen Research Topics

Disease

27Neoplasms (Cancer)
10/2006 - 01/2002
7Neoplasm Metastasis (Metastasis)
09/2004 - 01/2002
4Breast Neoplasms (Breast Cancer)
10/2006 - 01/2002
4Leukemia
09/2004 - 01/2002
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2005 - 12/2003
3Pathologic Neovascularization
06/2002 - 01/2002
2Carcinoma (Carcinomatosis)
11/2005 - 02/2005
2Carcinogenesis
05/2005 - 01/2004
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2004 - 08/2004
2Rheumatoid Arthritis
08/2004 - 11/2003
2Arthritis (Polyarthritis)
11/2003 - 08/2002
1Pica (Geophagia)
03/2007
1Weight Loss (Weight Reduction)
03/2007
1Necrosis
11/2005
1Glioblastoma (Glioblastoma Multiforme)
07/2005
1Glioma (Gliomas)
07/2005
1Multiple Myeloma
04/2005
1Hyperplasia
08/2004
1Hypersensitivity (Allergy)
08/2004
1Inflammation (Inflammations)
08/2004
1Psoriasis (Pustulosis Palmaris et Plantaris)
08/2004
1Wounds and Injuries (Trauma)
07/2004
1Colorectal Neoplasms (Colorectal Cancer)
01/2004
1Pancreatic Neoplasms (Pancreatic Cancer)
11/2002
1Disease Progression
08/2002
1Atherosclerosis
08/2002

Drug/Important Bio-Agent (IBA)

13Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2005 - 01/2002
10Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
11/2005 - 06/2002
9Monoclonal AntibodiesIBA
03/2007 - 05/2002
8AntibodiesIBA
03/2007 - 01/2002
8Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
10/2006 - 06/2002
5cadherin 5IBA
11/2005 - 05/2002
5ErbB Receptors (EGF Receptor)IBA
07/2005 - 11/2002
3LigandsIBA
10/2006 - 12/2003
3DC101 monoclonal antibodyIBA
11/2005 - 02/2005
3Cetuximab (Erbitux)FDA Link
07/2005 - 11/2002
3Epidermal Growth Factor (EGF)IBA
05/2005 - 11/2002
3Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2005 - 06/2002
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2004 - 01/2002
2Mitogen-Activated Protein KinasesIBA
10/2006 - 12/2003
2Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
10/2006 - 04/2005
2EpitopesIBA
06/2005 - 05/2002
2Somatomedin Receptors (Somatomedin Receptor)IBA
05/2005 - 01/2004
2Biological ProductsIBA
05/2005 - 08/2004
2E4G10 antibodyIBA
03/2005 - 05/2002
2Blocking AntibodiesIBA
08/2004 - 01/2002
2Growth Factor ReceptorsIBA
01/2004 - 12/2003
2Pharmaceutical PreparationsIBA
05/2002 - 01/2002
1SaltsIBA
03/2007
1fosbretabulin (combretastatin A4)IBA
11/2005
1TenascinIBA
11/2005
1beta CateninIBA
11/2005
1Peptide Hydrolases (Proteases)FDA Link
11/2005
1Bispecific AntibodiesIBA
05/2005
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
04/2005
1Platelet-Derived Growth Factor alpha ReceptorIBA
03/2005
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
03/2005
1CollagenIBA
02/2005
1Matrix Metalloproteinases (MMPs)IBA
02/2005
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
09/2004
1Interleukin-6 (Interleukin 6)IBA
09/2004
1Immunoglobulin G (IgG)IBA
08/2004
1IMC-EB10IBA
08/2004
1EnzymesIBA
08/2004
1Immunoglobulins (Immunoglobulin)IBA
08/2004
1ImmunosorbentsIBA
08/2004
1fms-Like Tyrosine Kinase 3IBA
08/2004
1Neutralizing AntibodiesIBA
08/2004
1IntegrinsIBA
07/2004
1Insulin-Like PeptidesIBA
12/2003
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
12/2003
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
12/2003
1Cell Surface ReceptorsIBA
12/2003
1VaccinesIBA
12/2003
1Hepatitis B e AntigensIBA
12/2003
1AntigensIBA
12/2003
1SHU 508 (Levovist)IBA
12/2003
1GlucuronidaseIBA
12/2002
1heparanaseIBA
12/2002
1Tyrosine (L-Tyrosine)FDA Link
11/2002
1GemcitabineFDA Link
11/2002
1AlginatesIBA
06/2002
1Angiogenesis InhibitorsIBA
06/2002
1Endothelial Growth FactorsIBA
05/2002
1Bromodeoxyuridine (BrdU)IBA
05/2002
1Immunoglobulin Fab FragmentsIBA
01/2002

Therapy/Procedure

5Therapeutics
05/2004 - 01/2002
1Aftercare (After-Treatment)
11/2005
1Immunotherapy
12/2003
1Microbubbles
12/2003
1Drug Therapy (Chemotherapy)
01/2002